|
Volumn 69, Issue 6, 2010, Pages 573-575
|
Human pharmacology of hydrogen sulfide, putative gaseous mediator
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ARGININE;
DICLOFENAC;
HEMOGLOBIN;
HYDROGEN SULFIDE;
MESALAZINE;
N(G) METHYLARGININE;
NITRIC OXIDE;
PROPARGYLGLYCINE;
SODIUM SULFIDE;
ANTIINFLAMMATORY ACTIVITY;
BIOLOGICAL ACTIVITY;
BIOSYNTHESIS;
CELL PROTECTION;
CENTRAL NERVOUS SYSTEM;
CONCENTRATION RESPONSE;
DRUG DISPOSITION;
DRUG EFFECT;
DRUG INHIBITION;
DRUG POTENCY;
DRUG SPECIFICITY;
DRUG SYNTHESIS;
EDITORIAL;
HEART MUSCLE ISCHEMIA;
HEART PERFUSION;
HUMAN;
LUNG VASOCONSTRICTION;
NONHUMAN;
PRIORITY JOURNAL;
STOMACH DISEASE;
VASCULAR SMOOTH MUSCLE;
VASODILATATION;
ANIMALS;
CARDIOVASCULAR SYSTEM;
HUMANS;
HYDROGEN SULFIDE;
INFUSIONS, INTRAVENOUS;
RATS;
SULFIDES;
|
EID: 77952036240
PISSN: 03065251
EISSN: 13652125
Source Type: Journal
DOI: 10.1111/j.1365-2125.2010.03690.x Document Type: Editorial |
Times cited : (18)
|
References (7)
|